Ostergaard, M., Olesen, L.H., Hasle, H., Kjeldsen, E. and Hokland, P. (2004) WT1 gene expression: An excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukemia patients-results from a singlecenter study. British Journal of Haematology, 125, 590-600. http://dx.doi.org/10.1111/j.1365-2141.2004.04952.x

has been cited by the following article:

• TITLE: Juvenile myelo-monocytic leukemia (JMML): No effect of granulocyte monocyte-colony stimulating factor (GM-CSF) on Wilms Tumor gene (WT1) by nested Polymerase Chain Reaction (nPCR) and flow cytometry

  AUTHORS: Sana Khan, Marie Olszewski, Wei Huang, Morris Kletzel

  KEYWORDS: Juvenile Myelo-Monocytic Leukemia; Wilms Tumor; Nested PCR; JMML; WT1; GM-CSF; nPCR

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.5 No.2, January 24, 2014

  ABSTRACT: This study was to determine whether GM-CSF induced WT1 gene expression and to establish an association with markers of proliferation CD71+CD34+ using nPCR and flow cytometry respectively, in samples obtained from 5 newly diagnosed JMML patients. Overtime (day 0 to day 14) there was an insignificant difference in WT1 gene expression and CD71+CD34+ in JMML samples when compared to peripheral blood of normal volunteers (n = 3). Our study suggests that there is a correlation between WT1 gene expression and cellular proliferation and that GMCSF in vitro does not create a significant difference in JMML samples.